albuterol has been researched along with 2019 Novel Coronavirus Disease in 13 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was a descriptive cohort study through a retrospective chart review from 2017 to 2022 analyzing ED visits for bronchiolitis including disposition, disease severity, chest radiographs, albuterol, and high flow nasal cannula usage." | 4.31 | The changing virology and trends in resource utilization for bronchiolitis since COVID-19. ( Burks, A; King, W; Orr, M, 2023) |
| "Patients admitted for asthma or COPD exacerbations, doctors, and nurses in a university-affiliated hospital were surveyed from 1 April 2021 to 30 September 2021 regarding their views on the effectiveness, ease of use, preparation and administration, side effects, and infection risk of the two administration methods." | 1.91 | Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease exacerbation: attitudes of patients and healthcare providers in the COVID-19 era. ( Alsuwaigh, R; Binte Mohd Noor, N; Cao, Y; Chen, H; Li, XL; Liew, J; Mohamed Noor, SB; Puan, Y; Tay, TR; Ye, H; Yii, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramey, OL | 1 |
| Silva Almodóvar, A | 1 |
| Nahata, MC | 1 |
| Alsuwaigh, R | 1 |
| Cao, Y | 1 |
| Puan, Y | 1 |
| Yii, A | 1 |
| Mohamed Noor, SB | 1 |
| Ye, H | 1 |
| Chen, H | 1 |
| Li, XL | 1 |
| Binte Mohd Noor, N | 1 |
| Liew, J | 1 |
| Tay, TR | 1 |
| Subat, YW | 1 |
| Meyer, TJ | 1 |
| Torgerud, KD | 1 |
| Lim, KG | 1 |
| Scanlon, PD | 1 |
| Niven, AS | 1 |
| Benítez-Angeles, M | 1 |
| Juárez-González, E | 1 |
| Vergara-Jaque, A | 1 |
| Llorente, I | 1 |
| Rangel-Yescas, G | 1 |
| Thébault, SC | 1 |
| Hiriart, M | 1 |
| Islas, LD | 1 |
| Rosenbaum, T | 1 |
| Faconti, L | 1 |
| Farukh, B | 1 |
| McNally, RJ | 1 |
| Brett, S | 1 |
| Chowienczyk, PJ | 1 |
| Burks, A | 1 |
| King, W | 1 |
| Orr, M | 1 |
| Casale, TB | 1 |
| Wang, J | 1 |
| Nowak-Wegrzyn, A | 1 |
| Codispoti, CD | 1 |
| Bandi, S | 1 |
| Patel, P | 1 |
| Mahdavinia, M | 1 |
| Amirav, I | 1 |
| Newhouse, MT | 1 |
| Weber, AG | 1 |
| Chau, AS | 1 |
| Egeblad, M | 1 |
| Barnes, BJ | 1 |
| Janowitz, T | 1 |
| Chaicoming, K | 1 |
| Preutthipan, A | 1 |
| Adirekkittikun, A | 1 |
| Nugboon, M | 1 |
| Mac Giolla Eain, M | 1 |
| O'Sullivan, A | 1 |
| Joyce, M | 1 |
| MacLoughlin, R | 1 |
| Guijon, OL | 1 |
| Morphew, T | 1 |
| Ehwerhemuepha, L | 1 |
| Galant, SP | 1 |
2 trials available for albuterol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series.
Topics: Adult; Aged; Albuterol; Bronchodilator Agents; Coronavirus Infections; COVID-19; Deoxyribonuclease I | 2020 |
Homemade valved holding chambers for children with airway hyperresponsiveness: A randomized crossover trial.
Topics: Administration, Inhalation; Adolescent; Albuterol; Bronchodilator Agents; Child; COVID-19; Cross-Ove | 2021 |
11 other studies available for albuterol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Medication adherence in Medicare-enrolled older adults with asthma before and during the coronavirus disease 2019 pandemic.
Topics: Aged; Albuterol; Anti-Asthmatic Agents; Asthma; COVID-19; COVID-19 Drug Treatment; Humans; Medicare; | 2022 |
Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Attitude of Health Personnel; Bronchodilator A | 2023 |
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; COVID-19; Equipment Design; | 2022 |
Unconventional interactions of the TRPV4 ion channel with beta-adrenergic receptor ligands.
Topics: Albuterol; COVID-19; Humans; Ligands; Receptors, Adrenergic, beta; Transient Receptor Potential Chan | 2023 |
Impaired β 2 -adrenergic endothelium-dependent vasodilation in patients previously hospitalized with coronavirus disease 2019.
Topics: Adrenergic Agents; Albuterol; COVID-19; Endothelium, Vascular; Humans; Hypertension; Male; Sildenafi | 2023 |
The changing virology and trends in resource utilization for bronchiolitis since COVID-19.
Topics: Albuterol; Bronchiolitis; Cohort Studies; COVID-19; Humans; Infant; Pandemics; Respiratory Syncytial | 2023 |
Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic.
Topics: Albuterol; Algorithms; Anaphylaxis; Blood Pressure Determination; Bronchodilator Agents; Coronavirus | 2020 |
Clinical course of asthma in 4 cases of coronavirus disease 2019 infection.
Topics: Acetates; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Betacoronavirus; Black or African America | 2020 |
COVID-19: Time to embrace MDI+ valved-holding chambers!
Topics: Administration, Inhalation; Albuterol; Asthma; Betacoronavirus; Bronchodilator Agents; Coronavirus I | 2020 |
In vitro evaluation of disposable transport ventilators with combination aerosol therapy.
Topics: Administration, Inhalation; Aerosols; Albuterol; COVID-19; Disposable Equipment; Drug Delivery Syste | 2021 |
Evaluating the impact of coronavirus disease 2019 on asthma morbidity: A comprehensive analysis of potential influencing factors.
Topics: Adolescent; Adrenal Cortex Hormones; Albuterol; Asthma; California; Child; Child, Preschool; COVID-1 | 2021 |